The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.
Saved in:
| Title: | The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer. |
|---|---|
| Authors: | Vitale SR; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Clinical and Experimental Medicine, University of Catania, 95123, Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico- San Marco', 95123, Catania, Italy., Ruigrok-Ritstier K; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Foekens R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Trapman-Jansen AMAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Vigneri P; Department of Clinical and Experimental Medicine, University of Catania, 95123, Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico- San Marco', 95123, Catania, Italy., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cancer Genomics Netherlands, Rotterdam, The Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cancer Genomics Netherlands, Rotterdam, The Netherlands., Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. m.p.h.m.jansen@erasmusmc.nl. |
| Source: | BMC cancer [BMC Cancer] 2022 Feb 12; Vol. 22 (1), pp. 165. Date of Electronic Publication: 2022 Feb 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35151276 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vitale+SR%22">Vitale SR</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Clinical and Experimental Medicine, University of Catania, 95123, Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico- San Marco', 95123, Catania, Italy.<br /><searchLink fieldCode="AU" term="%22Ruigrok-Ritstier+K%22">Ruigrok-Ritstier K</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Timmermans+AM%22">Timmermans AM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Foekens+R%22">Foekens R</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Trapman-Jansen+AMAC%22">Trapman-Jansen AMAC</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Beaufort+CM%22">Beaufort CM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vigneri+P%22">Vigneri P</searchLink>; Department of Clinical and Experimental Medicine, University of Catania, 95123, Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico- San Marco', 95123, Catania, Italy.<br /><searchLink fieldCode="AU" term="%22Sleijfer+S%22">Sleijfer S</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Martens+JWM%22">Martens JWM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cancer Genomics Netherlands, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sieuwerts+AM%22">Sieuwerts AM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cancer Genomics Netherlands, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jansen+MPHM%22">Jansen MPHM</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. m.p.h.m.jansen@erasmusmc.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2022 Feb 12; Vol. 22 (1), pp. 165. <i>Date of Electronic Publication: </i>2022 Feb 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35151276 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-022-09265-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 165 Titles: – TitleFull: The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vitale SR – PersonEntity: Name: NameFull: Ruigrok-Ritstier K – PersonEntity: Name: NameFull: Timmermans AM – PersonEntity: Name: NameFull: Foekens R – PersonEntity: Name: NameFull: Trapman-Jansen AMAC – PersonEntity: Name: NameFull: Beaufort CM – PersonEntity: Name: NameFull: Vigneri P – PersonEntity: Name: NameFull: Sleijfer S – PersonEntity: Name: NameFull: Martens JWM – PersonEntity: Name: NameFull: Sieuwerts AM – PersonEntity: Name: NameFull: Jansen MPHM IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 02 Text: 2022 Feb 12 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 22 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |